Sergey Brin bankrolls startup using hallucinogens for mental health
[ad_1] Google cofounder Sergey Brin got a $366 million windfall from selling all his Tesla shares back in 2021—now he’s using some of the funds
What are Kamala Harris’ trade policies?
[ad_1] Over her career in politics Harris has twice opposed major trade deals that she deemed good but not good enough. As a Senator and
AI could be the best long-term disinflationary force in a challenging global economy
[ad_1] Inflation has moderated from peak levels last year, but as recent numbers show, it’s still not as low as anyone would like it to
Homebuyers are backing out of deals at a record pace
[ad_1] Deals are falling through in the housing world. Roughly 56,000 home purchase agreements were called off last month, which translates to almost 15% of
Tesla delays Optimus robots | Fortune
[ad_1] Tesla’s Optimus robots are going to be late to work. In a tweet Monday, Elon Musk wrote “Tesla will have genuinely useful humanoid robots
The SEC bungled a crypto lawsuit. Then came an alleged kidnapping in Dubai—and questions about $400 million of investors’ funds
[ad_1] The saga couldn’t get any stranger. After facing an existential lawsuit from the Securities and Exchange Commission late last year, Wyoming-based crypto company Debt
Netflix has 80 games in development
[ad_1] Netflix could be on its way to becoming one of the most prolific video game publishers in the industry. The company, on its latest
Beyond Meat’s new product isn’t meant to replicate meat
[ad_1] Beyond Meat is introducing a new sausage to its lineup, but unlike the company’s other offerings, this plant-based protein product is not meant to
Biden follows a long line of Western leaders who voluntarily surrendered power at the end of a ‘heroic journey,’ says the author of The Hero’s Farewell
[ad_1] Anyone who scanned yesterday’s headlines will realize why top leaders in business and government are reluctant to exit. There were eight front-page pieces in the New
An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value
[ad_1] The 25 people in Roche Holding AG’s obesity pill study would barely be enough to field both sides of a soccer match. Yet their